We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CTKB market cap is 495.91M. The company's latest EPS is USD -0.58 and P/E is -6.5.
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 41.46M | 45.6M | 52.29M | 62.14M | 44.14M |
| Operating Income | -14.98M | -10.62M | -9.19M | -5.59M | -18.46M |
| Net Income | -11.4M | -5.58M | -5.48M | -44.08M | -18.87M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 127.95M | 164.04M | 193.02M | 200.45M | 201.49M |
| Operating Income | 9.16M | -1.8M | -27.85M | -20.52M | -40.38M |
| Net Income | 3.05M | 2.58M | -12.15M | -6.02M | -66.54M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 482.6M | 493.32M | 494.92M | 461.54M | 449.11M |
| Total Liabilities | 102.97M | 115.76M | 116.35M | 119.8M | 121.47M |
| Total Equity | 379.62M | 377.56M | 378.57M | 341.74M | 327.64M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 463.31M | 519.48M | 494.46M | 499.5M | 461.54M |
| Total Liabilities | 57.92M | 93.93M | 101.39M | 103.76M | 119.8M |
| Total Equity | 405.39M | 425.55M | 393.06M | 395.74M | 341.74M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -125k | 108k | -3.9M | -771k | -2.74M |
| Investing | 9.45M | -16.41M | 18.92M | -1.84M | -27.08M |
| Financing | -11.55M | -2.6M | 1.94M | -1.23M | 3.98M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 4.63M | -12.23M | 5.28M | 25.38M | -4.69M |
| Investing | -20.99M | -55.91M | -93.89M | -82.97M | 10.12M |
| Financing | 213.56M | 5.51M | -41.81M | -15.82M | -13.43M |
| Market Cap | 495.908M |
| Price to Earnings Ratio | -6.50 |
| Price to Sales Ratio | 2.38 |
| Price to Cash Ratio | 0.51 |
| Price to Book Ratio | 1.49 |
| Dividend Yield (LTM) | N/A |
| Shares Outstanding | 129.14M |
| Average Volume (1 week) | 6.04M |
| Average Volume (1 Month) | 2.19M |
| 52 Week Change | 31.51% |
| 52 Week High | 6.18 |
| 52 Week Low | 2.90 |
| Spread (Intraday) | 0.16 (4.04%) |
| Company Name | Cytek Biosciences Inc |
| Address |
47215 Lakeview Blvd Fremont, California 94538-6407 |
| Website | https://cytekbio.com |
| Industry | Biotechnology & Life Sciences |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Register with Email
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.
Hot Features
Premium
